Clearable Theranostic Platform with pH-independent Chemodynamic Therapy Enhancement Strategy for Synergetic Photothermal Tumor Therapy.

Qian Chen,Yu Luo,Wenxian Du,Zhuang Liu,Shengjian Zhang,Jiahui Yang,Heliang Yao,Tianzhi Liu,Ming Ma,Hangrong Chen
DOI: https://doi.org/10.1021/acsami.9b02905
IF: 9.5
2019-01-01
ACS Applied Materials & Interfaces
Abstract:Chemodynamic therapy (CDT) is an emerging field, which utilizes intratumoral iron-mediated Fenton chemistry for cancer therapy. However, the slightly acidic tumor environment is improper for the classical Fenton reaction which is generally energetic at a narrow pH range (e.g., pH=3-4). Herein, a kind of ultrasmall bovine serum albumin(BSA)-modified chalcopyrite nanoparticles (BSA-CuFeS2 NPs) was synthesized via a facile aqueous biomineralization strategy, which shows high dispersity and biocompatibility. Interestingly, the obtained BSA-CuFeS2 shows a pH-independent Fenton-like reaction, which could exert Fenton-like activity to efficiently generate •OH at the weak acidic tumor environment. Combining with the extraordinarily high photothermal conversion (38.8%), BSA-CuFeS2 shows the synergistic effect of high photothermal therapy and enhanced chemodynamic therapy in vivo, i.e, PTT/CDT. Importantly, such ultrasmall BSA-CuFeS2 NPs with around 4.9 nm can be rapidly excreted from the body through the kidneys and liver, thus effectively avoiding long-term toxicity and systemic toxicity. This work provides a universal method to boost the production of •OH by a pH-independent Fenton-like reaction strategy and achieves MRI-guided synergistic enhanced photothermal-chemodynamic therapy for high efficient tumor treatment.
What problem does this paper attempt to address?